Kew Gardens, NY, United States of America

Matthew Miller

This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Forest Laboratories Holdings Limited. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Miller. Retrieved from https://idiyas.com/inventor/matthew-miller-4l0ak39l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthew Miller - Innovator in Gastrointestinal Treatments

Introduction

Matthew Miller is a notable inventor based in Kew Gardens, NY (US). He has made significant contributions to the field of gastrointestinal treatments through his innovative work. His dedication to improving patient care is evident in his patented inventions.

Latest Patents

Matthew Miller holds a patent for linaclotide compositions. This invention is directed to stable linaclotide compositions and methods of treating gastrointestinal disorders in patients in need thereof by providing the stable linaclotide compositions. His work in this area has the potential to greatly benefit individuals suffering from such disorders.

Career Highlights

Matthew Miller is associated with Forest Laboratories Holdings Limited, where he continues to develop and refine his inventions. His role in the company allows him to collaborate with other talented professionals in the field.

Collaborations

Some of his coworkers include Yun Mo and Mohammad Mafruhul Bari. Their collective expertise contributes to the innovative environment at Forest Laboratories Holdings Limited.

Conclusion

Matthew Miller's contributions to the field of gastrointestinal treatments through his patent for linaclotide compositions highlight his commitment to advancing medical science. His work exemplifies the impact that dedicated inventors can have on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…